摘要
目的:探讨培美曲塞联合顺铂治疗中、晚期肺腺癌的临床疗效。方法:经病理确诊为肺腺癌的60例患者,采用培美曲塞联合顺铂全身化疗。结果:所有患者SD21例,PR18例,PD3例,总疾病控制率为91.2%,客观有效率为42.3%。结论:培美曲塞联合顺铂治疗中、晚期肺腺癌疗效肯定,安全性好。
Objective: To study the therapy efficacy of treating advanced lung adenocarcinoma with pemetrexed joint cisplatin. Methods: Select 60 cases of patients with advanced lung adenocarcinoma and give them pemetrexed joint cisplatin treatment. Results: Among all the patients,21 cases were SD,18 cases were PR,3cases were PD,the whole control rate was 91. 2%,the objective effective rate was 42. 3%. Conclusion: Treating advanced lung adenocarcinoma with pemetrexed joint cisplatin haas remarkable effect and high safety.
出处
《数理医药学杂志》
2016年第3期405-407,共3页
Journal of Mathematical Medicine
关键词
培美曲塞
顺铂
肺腺癌
疗效观察
pemetrexed
cisplatin
lung adenocarcinoma
efficacy observation
